AssetMark Inc
AGIO icon

AssetMark Inc’s Agios Pharmaceuticals AGIO Stock Holding History

AssetMark Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.9K Hold
1,317
– – ﹤0.01% 1840
2026
Q1 		$44.6K Hold
1,317
– – ﹤0.01% 1787
2025
Q4 		$35.8K Buy
1,317
+362
+38% +$12.7K ﹤0.01% 1825
2025
Q3 		$38.3K Hold
955
– – ﹤0.01% 1724
2025
Q2 		$31.8K Buy
955
+150
+19% +$4.55K ﹤0.01% 1685
2025
Q1 		$23.6K Buy
805
+250
+45% +$8.29K ﹤0.01% 1665
2024
Q4 		$18.2K Hold
555
– – ﹤0.01% 1675
2024
Q3 		$24.7K Hold
555
– – ﹤0.01% 1451
2024
Q2 		$23.9K Hold
555
– – ﹤0.01% 1354
2024
Q1 		$16.2K Buy
+555
New +$14.9K ﹤0.01% 1315

Other funds holding AGIO

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

AssetMark Inc's AGIO Position: Q2 2026 in Review

AssetMark Inc held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 1,317 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

AssetMark Inc first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. 45 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • AssetMark Inc held 1,317 shares of Agios Pharmaceuticals worth $48.9K as of Q2 2026.
  • AssetMark Inc left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1840 holding.
  • AssetMark Inc first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 45 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.